EUVIMEDEUVIMED entdecken
Multizentrische Studie

Perioperative and long-term outcomes after Hemodialysis Reliable Outflow (HeRO) graft surgery

Young Kim, Christina L Cui, Anthony Nnaemeka Eze, Tristen T Chun, Charles Y Kim, Ellen D Dillavou, Mitchell W Cox, Kevin W Southerland

Journal of Vascular Surgery · 2025

DOI: 10.1016/j.jvs.2025.05.042 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Vascular Surgery, 2025. Verfasst von Young Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, Department of Surgery, Duke University Medical Center, Durham, NC. Hauptthemen laut MEDLINE: Renal Dialysis, Arteriovenous Shunt, Surgical, Blood Vessel Prosthesis Implantation, Graft Occlusion, Vascular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The Hemodialysis Reliable Outflow (HeRO) graft offers hemodialysis access options for patients who have developed central venous stenosis or occlusion. In this single-center study, we report our perioperative and long-term outcomes after HeRO graft placement, and investigate the impact of conduit type and configuration on patency rates. METHODS: We retrospectively reviewed all HeRO graft procedures performed from January 2014 to December 2023 across three hospitals. Data were collected on patient demographics, operative details, postoperative outcomes, and patency. Only index HeRO graft procedures were included, and any subsequent or reoperative HeRO operations were excluded from analysis. Cox proportional hazards model was used to derive risk factors for loss of graft patency. RESULTS: A total of 232 index HeRO implantations were performed over the 10-year study period. These included 49 primary procedures (23.1%) and 183 staged procedures (78.9%). Postoperative complications included wound infection (n = 18; 7.8%), symptomatic hematoma (n = 23; 9.9%), steal syndrome (n = 23; 9.9%), myocardial infarction (n = 3; 1.3%), and pulmonary embolism (n = 7; 3.0%). Overall primary patency was 33.0% ± 3.4% at 1 year, 6.4% ± 2.1% at 3 years, and 4.3% ± 1.9% at 5 years post-implantation. Secondary patency was 69.4% ± 3.4% at 1 year, 41.9% ± 4.4% at 3 years, and 28.0% ± 4.9% at 5 years post-implantation. Primary and secondary patency rates did not differ between primary and staged procedures (log-rank P = .46 and .73, respectively). On multivariate analysis, the use of a tapered 4- to 6-mm (hazard ratio [HR], 2.89; 95% confidence interval [CI], 1.11-7.49; P = .029) or tapered 4- to 7-mm conduit (HR, 1.82; 95% CI, 1.15-2.87; P = .011) was independently associated with loss of primary patency, compared with a non-tapered 6-mm graft. Tapered conduits were also associated with loss of secondary patency (4- to 6-mm tapered: HR, 3.68; 95% CI, 1.07-12.63; P = .039; 4- to 7-mm tapered: HR, 1.85; 95% CI, 1.01-3.37; P = .044). Neither graft type (standard vs early cannulation) nor procedure (primary vs staged) were associated with loss of primary or secondary patency. CONCLUSIONS: Among patients with limited hemodialysis access options, HeRO graft implantation is associated with limited primary patency but acceptable secondary graft patency rates. In our experience, staged procedures and early cannulation grafts did not impact patency rates; however, the use of a tapered conduit was associated with loss of patency and should be considered with caution in this patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisArteriovenous Shunt, SurgicalBlood Vessel Prosthesis ImplantationGraft Occlusion, VascularBlood Vessel ProsthesisHumansRetrospective StudiesMaleFemaleVascular PatencyMiddle AgedTime FactorsAgedRisk FactorsTreatment OutcomeRisk AssessmentProsthesis DesignPostoperative Complications

Stichwörter der Autor:innen

Central venous stenosisDialysis accessEnd-stage renal disease

Autor:innen und Institutionen

  • Division of Vascular and Endovascular Surgery, Department of Surgery, Duke University Medical Center, Durham, NC.
  • Division of Interventional Radiology, Department of Radiology, Duke University Medical Center, Durham, NC.
  • Division of Vascular Surgery, Department of Surgery, WakeMed Health System, Raleigh, NC.
  • Division of Vascular and Endovascular Surgery, Department of Surgery, University of Texas Medical Branch, Galveston, TX.
  • Division of Vascular and Endovascular Surgery, Department of Surgery, Duke University Medical Center, Durham, NC. Electronic address: kevin.southerland@duke.edu.

Zitieren

APA

Kim, Y., Cui, C. L., Eze, A. N., Chun, T. T., Kim, C. Y., Dillavou, E. D., Cox, M. W., & Southerland, K. W. (2025). Perioperative and long-term outcomes after Hemodialysis Reliable Outflow (HeRO) graft surgery. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2025.05.042

Vancouver

Kim Y, Cui CL, Eze AN, Chun TT, Kim CY, Dillavou ED, et al. Perioperative and long-term outcomes after Hemodialysis Reliable Outflow (HeRO) graft surgery. Journal of Vascular Surgery. 2025. doi:10.1016/j.jvs.2025.05.042

BibTeX
@article{Kim2025,
  author = {Kim, Young and Cui, Christina L and Eze, Anthony Nnaemeka and Chun, Tristen T and Kim, Charles Y and Dillavou, Ellen D and Cox, Mitchell W and Southerland, Kevin W},
  title = {Perioperative and long-term outcomes after Hemodialysis Reliable Outflow (HeRO) graft surgery},
  journal = {Journal of Vascular Surgery},
  year = {2025},
  doi = {10.1016/j.jvs.2025.05.042}
}
Kostenlos starten →